Clinical trial
A Phase I Trial of ZIO-101 in Solid Tumors: Protocol # SGL1002
NCT00591396 is registered in ClinicalTrials.gov with Alaunos Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Trial of ZIO-101 in Solid Tumors: Protocol # SGL1002
- Lead sponsor
- Alaunos Therapeutics
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 31, 2005
- Completion date
- July 31, 2008
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
solid tumors